Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]
Bio2RDF identifier
NCT00004255
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00004255
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Bone marrow ...... bone marrow transplantation.
brief title [clinicaltrials_vocabulary:brief-title]
Treatment of Bone Marrow to Pr ...... ng Bone Marrow Transplantation
completion date [clinicaltrials_vocabulary:completion-date]
2003-05-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... this study within 17 months.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-01-28T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
accelerated phase chronic myelogenous leukemia
adult acute lymphoblastic leukemia in remission
adult acute myeloid leukemia in remission
childhood acute lymphoblastic leukemia in remission
childhood acute myeloid leukemia in remission
childhood myelodysplastic syndromes
chronic phase chronic myelogenous leukemia
de novo myelodysplastic syndromes
graft versus host disease
previously treated myelodysplastic syndromes
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-07-09T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00004255
official title [clinicaltrials_vocabulary:official-title]
A Multi-Center, Open Label, Ra ...... With Acute or Chronic Leukemia
org study id [clinicaltrials_vocabulary:org-study-id]
CHIMERIC-HM01
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
CDR0000067502
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2000-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2002-02-01T00:00:00Z
identifier
clinicaltrials:NCT00004255
title
Treatment of Bone Marrow to Pr ...... ng Bone Marrow Transplantation
@en
type
label
Treatment of Bone Marrow to Pr ...... n [clinicaltrials:NCT00004255]
@en